Skip to main content

27 November 2025

Last updated: Wednesday 26 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A US approach to value-based drug assessment

Sunday 13 December 2015

Interviewee/Contributor

Steven D. Pearson

Organisation

Institute for Clinical and Economic Review

Organisations

Independent healthcare analyst
BerGenBio ASA
McKenna, Long & Aldridge
GfK Bridgehead
Mission Therapeutics
Odlander, Fredrikson and Co AB
Quell Therapeutics Ltd
RhoVac AB
Destiny Pharma Plc
BioAlliance

Interviewees and Contributers

Tim Edwards
Khalid Ishaque
Will West
Priya Kalia and Miranda Weston-Smith
Michael Valenzuela
Andrea Pfeifer
Richard Zimmerman
Walter Schmidt
Johan Christenson
Kevin FitzGerald

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form